Commission and Commissioner Statements
Statement of the Federal Trade Commission Regarding the Decision to Close Its Investigation into the Conduct of Akzo Nobel, NV and Its Organon Subsidiary (2004) Statement by Federal Trade Commission Chairman Timothy J. Muris on Generic Paxil Launch (related to GlaxoSmithKline’s delisting from the FDA Orange Book of three Paxil-related patents, 2003) Statement of FTC Chairman Supporting FDA's Final Generic Drug Rule (June 12, 2003)
Last Updated: Tuesday, February 5, 2008 5:23 PM->->->->